Effect of rhEGF activating extracellular signal-regulated kinase on the expression of Bcl-2 and p53 protein in human amniotic cells

YUAN Qing-feng,XU Li-hong,CHEN Jia-ping,ZHOU Wen,CHEN Shu-jie,SI Jian-min
DOI: https://doi.org/10.3321/j.issn:1000-4718.2007.11.041
2007-01-01
Abstract:AIM: To explore the effect of recombinant human epidermal growth factor (rhEGF) on the ERK1/2 pathway and its safety in use when the proliferation of cultured FL cells (human amnion epithelial cells) were promoted by rhEGF.METHODS: FL cells were stimulated by rhEGF at various concentrations. The proliferation rate of FL cells was evaluated by MTT assay. Western blotting was used to detect phosphorylation of ERK1/2 (p-ERK1/2) and the change of Bcl-2 and P53 protein. RESULTS: The proliferation rate FL cells reached the maximum when the concentration of rhEGF was 10 μg/L (42.4%,P<0.01). Western blotting showed that the activity of p-ERK1/2 increased significantly when rhEGF ranged in 10 μg/L to 60 μg/L. Level of Bcl-2 was unchanged in each groups. Level of P53 decreased significantly when the concentration of rhEGF was 60 μg/L.CONCLUSION: It is safe when rhEGF presents in optimization concentration of 10 μg/L. The capability of apoptosis may be depressed when rhEGF is in larger dose.
What problem does this paper attempt to address?